OxCan (Oxford Cancer Analytics)
Oxford, GB · 2 known investors
Oxford Cancer Analytics develops a diagnostic platform that combines proteomic measurement with AI to generate evidence-based clinical insights for lung disease management, initially focused on COPD and lung cancer.
AI & Machine LearningDigital HealthMedical Devices